Terms: = Gastric cancer AND Ki-67 AND Staging
27 results:
1. gastric NEUROENDOCRINE TUMOR: WHEN SURGICAL TREATMENT IS INDICATED?
Assis Filho AC; Tercioti Junior V; Andreollo NA; Ferrer JAP; Coelho Neto JS; Lopes LR
Arq Bras Cir Dig; 2023; 36():e1768. PubMed ID: 37851754
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
[TBL] [Abstract] [Full Text] [Related]
3. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
4. THE ROLE OF CONVENTIONAL ECHOENDOSCOPY (EUS) IN THERAPEUTIC DECISIONS IN PATIENTS WITH NEUROENDOCRINE GASTROINTESTINAL TUMORS.
Costa RDD; Kemp R; Santos JSD; Costa DAPD; Ardengh JC; Ribas-Filho JM; Ribas CAPM
Arq Bras Cir Dig; 2020; 33(2):e1512. PubMed ID: 32844878
[TBL] [Abstract] [Full Text] [Related]
5. Dual Energy Spectral CT Imaging in the assessment of gastric cancer and cell proliferation: A Preliminary Study.
Cheng SM; Ling W; Zhu J; Xu JR; Wu LM; Gong HX
Sci Rep; 2018 Dec; 8(1):17619. PubMed ID: 30514959
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
[TBL] [Abstract] [Full Text] [Related]
7. G3 GEP NENs category: are basic and clinical investigations well integrated?
Milione M; Fazio N
Endocrine; 2018 Apr; 60(1):28-30. PubMed ID: 28733935
[TBL] [Abstract] [Full Text] [Related]
8. [Establishment of risk model for predicting the progression within 1 year of patients with gastric neuroendocrine neoplasms and its value of prediction].
Peng X; Zhang Y; Bao Y; Zhou L; Muo Z; Chen H; Zhi F; Liu S; Chen J; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1247-1251. PubMed ID: 27928794
[TBL] [Abstract] [Full Text] [Related]
9. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of the concordance between the stage of the disease and ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract] [Full Text] [Related]
11. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract] [Full Text] [Related]
13. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer.
Jo MJ; Park JY; Song JS; Kook MC; Ryu KW; Cho SJ; Lee JH; Nam BH; Hong EK; Choi IJ; Kim YW
World J Gastroenterol; 2015 Jan; 21(2):667-74. PubMed ID: 25593497
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
Karakuş E; Helvacı A; Ekinci O; Dursun A
Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
[TBL] [Abstract] [Full Text] [Related]
15. gastric and duodenal neuroendocrine tumours.
O'Toole D; Delle Fave G; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract] [Full Text] [Related]
17. Combined evaluation of centromere protein H and ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract] [Full Text] [Related]
18. Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute.
Kubota T; Ohyama S; Hiki N; Nunobe S; Yamamoto N; Yamaguchi T
Gastric Cancer; 2012 Jul; 15(3):323-30. PubMed ID: 22252152
[TBL] [Abstract] [Full Text] [Related]
19. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract] [Full Text] [Related]
[Next]
